Climb Bio (CLYM) announced that the company will be added to the NASDAQ Biotech Index (NBI) as part of the annual reconstitution of the 2024 Nasdaq indexes. Climb Bio’s inclusion in the Nasdaq Biotechnology Index will be effective prior to market open on Monday, December 23, 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLYM:
Questions or Comments about the article? Write to editor@tipranks.com